Gustavo A. Rosario Benitez

Array ( [id] => 369951 [patent_doc_number] => 07476724 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-13 [patent_title] => 'Humanized anti-cmet antibodies' [patent_app_type] => utility [patent_app_number] => 11/196917 [patent_app_country] => US [patent_app_date] => 2005-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 39945 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/476/07476724.pdf [firstpage_image] =>[orig_patent_app_number] => 11196917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7247558 [patent_doc_number] => 20050272126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Testis-specific differentiation-regulatory factor' [patent_app_type] => utility [patent_app_number] => 11/192374 [patent_app_country] => US [patent_app_date] => 2005-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6932 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272126.pdf [firstpage_image] =>[orig_patent_app_number] => 11192374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5295959 [patent_doc_number] => 20090010885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Methods for Detecting and Treating Autoimmune Disorders' [patent_app_type] => utility [patent_app_number] => 11/658834 [patent_app_country] => US [patent_app_date] => 2005-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 23360 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20090010885.pdf [firstpage_image] =>[orig_patent_app_number] => 11658834 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7220260 [patent_doc_number] => 20050260693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Tumor suppressor gene' [patent_app_type] => utility [patent_app_number] => 11/060005 [patent_app_country] => US [patent_app_date] => 2005-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 88 [patent_figures_cnt] => 88 [patent_no_of_words] => 34121 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20050260693.pdf [firstpage_image] =>[orig_patent_app_number] => 11060005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5819995 [patent_doc_number] => 20060024308 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'High affinity anti-TNF-alpha antibodies and method' [patent_app_type] => utility [patent_app_number] => 11/176525 [patent_app_country] => US [patent_app_date] => 2005-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 21972 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20060024308.pdf [firstpage_image] =>[orig_patent_app_number] => 11176525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5264417 [patent_doc_number] => 20090117102 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'Methods and compositions using CD3 agonists' [patent_app_type] => utility [patent_app_number] => 11/630946 [patent_app_country] => US [patent_app_date] => 2005-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30352 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20090117102.pdf [firstpage_image] =>[orig_patent_app_number] => 11630946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1076702 [patent_doc_number] => 07615213 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-10 [patent_title] => 'Antibodies against human interleukin-13 and pharmaceutical compositions thereof' [patent_app_type] => utility [patent_app_number] => 11/149309 [patent_app_country] => US [patent_app_date] => 2005-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 49 [patent_no_of_words] => 41343 [patent_no_of_claims] => 85 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/615/07615213.pdf [firstpage_image] =>[orig_patent_app_number] => 11149309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5894393 [patent_doc_number] => 20060002932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Methods and compositions for enhancement of immunity by in vivo depletion of immunosuppressive cell activity' [patent_app_type] => utility [patent_app_number] => 11/144083 [patent_app_country] => US [patent_app_date] => 2005-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 27207 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20060002932.pdf [firstpage_image] =>[orig_patent_app_number] => 11144083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 102640 [patent_doc_number] => 07728114 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-01 [patent_title] => 'Anti-CD3 antibodies and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/145131 [patent_app_country] => US [patent_app_date] => 2005-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 28 [patent_no_of_words] => 22042 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/728/07728114.pdf [firstpage_image] =>[orig_patent_app_number] => 11145131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5732289 [patent_doc_number] => 20060257406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Ligand' [patent_app_type] => utility [patent_app_number] => 11/141661 [patent_app_country] => US [patent_app_date] => 2005-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 52616 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20060257406.pdf [firstpage_image] =>[orig_patent_app_number] => 11141661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7243547 [patent_doc_number] => 20050271659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Novel T-cell membrane protein (TIRC7), peptides and antibodies derived therefrom and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/126841 [patent_app_country] => US [patent_app_date] => 2005-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 19178 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0271/20050271659.pdf [firstpage_image] =>[orig_patent_app_number] => 11126841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4697816 [patent_doc_number] => 20080220000 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'Methods for Generating Improved Immune Reponse' [patent_app_type] => utility [patent_app_number] => 11/579190 [patent_app_country] => US [patent_app_date] => 2005-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10644 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20080220000.pdf [firstpage_image] =>[orig_patent_app_number] => 11579190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5636941 [patent_doc_number] => 20060067914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Immortalized natural killer cell line' [patent_app_type] => utility [patent_app_number] => 11/114904 [patent_app_country] => US [patent_app_date] => 2005-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7195 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0067/20060067914.pdf [firstpage_image] =>[orig_patent_app_number] => 11114904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10863447 [patent_doc_number] => 08889136 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-18 [patent_title] => 'Multiple-variable dose regimen for treating TNFα-related disorders' [patent_app_type] => utility [patent_app_number] => 11/104117 [patent_app_country] => US [patent_app_date] => 2005-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 44764 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11104117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5769468 [patent_doc_number] => 20050265993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Methods of treating autoimmune and inflammatory diseases' [patent_app_type] => utility [patent_app_number] => 11/099716 [patent_app_country] => US [patent_app_date] => 2005-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7429 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20050265993.pdf [firstpage_image] =>[orig_patent_app_number] => 11099716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5769491 [patent_doc_number] => 20050266001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Therapeutic blockade of CD103 interactions to prevent clinical renal allograft rejection' [patent_app_type] => utility [patent_app_number] => 11/097125 [patent_app_country] => US [patent_app_date] => 2005-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11507 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20050266001.pdf [firstpage_image] =>[orig_patent_app_number] => 11097125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7201937 [patent_doc_number] => 20050165223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Novel serine protease BSSP2' [patent_app_type] => utility [patent_app_number] => 11/087701 [patent_app_country] => US [patent_app_date] => 2005-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15060 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20050165223.pdf [firstpage_image] =>[orig_patent_app_number] => 11087701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7225351 [patent_doc_number] => 20050255105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Severe myelin deficits induced by self-reactive gamma delta T cells' [patent_app_type] => utility [patent_app_number] => 11/088159 [patent_app_country] => US [patent_app_date] => 2005-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17273 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20050255105.pdf [firstpage_image] =>[orig_patent_app_number] => 11088159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5119346 [patent_doc_number] => 20070141060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Hmgb1 protein inhibitors for the regulation of smooth muscle cells and endothelial cells profileration' [patent_app_type] => utility [patent_app_number] => 10/586752 [patent_app_country] => US [patent_app_date] => 2005-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 916 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20070141060.pdf [firstpage_image] =>[orig_patent_app_number] => 10586752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6951780 [patent_doc_number] => 20050226874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Mutant fab fragments of the chimeric 13B8.2 anti-CD4 antibody and their applications' [patent_app_type] => utility [patent_app_number] => 11/029574 [patent_app_country] => US [patent_app_date] => 2005-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12902 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20050226874.pdf [firstpage_image] =>[orig_patent_app_number] => 11029574 [rel_patent_id] =>[rel_patent_doc_number] =>)